• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $400B Brain-Computer Interface (BCI) Market

    4/1/25 10:00:00 AM ET
    $MDBH
    Finance: Consumer Services
    Finance
    Get the next $MDBH alert in real time by email

    Dallas, TX, April 01, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence and strategy firm, has released its latest PatentVest Pulse report on brain-computer interfaces (BCIs). Titled "Brain-Computer Interfaces (BCIs): Who's Leading, What They Own, and How IP Will Decide the Future," the report reveals how control over intellectual property—not just innovation—is shaping the future of neurotechnology.

    Neurological disorders represent one of the fastest-growing and highest-need areas in global healthcare, with millions affected by conditions such as paralysis, epilepsy, stroke, and treatment-resistant depression. As traditional treatments struggle to deliver meaningful outcomes, BCIs are emerging as a next-generation solution—restoring lost function, enabling new capabilities, and shifting neurological care from reactive to proactive.

    The U.S. market for BCIs is projected to exceed $400 billion. Approximately $80 billion is concentrated in high-acuity, early-adopting patient populations already aligning with clinical and reimbursement pathways. A further $320 billion in long-term potential lies in broader neurological and psychiatric conditions, where early alignment of intellectual property, clinical validation, and commercialization strategy will be critical to scaling. While the opportunity is vast, long-term value will accrue to the companies that move early to secure technical, clinical, and IP leadership.

    This report delivers a first-of-its-kind strategic lens into the BCI market—combining deep company-level benchmarking with a comprehensive IP landscape analysis. It profiles the clinical strategies, platform architectures, and patent portfolios of the most prominent BCI players—including Synchron, Neuralink, Blackrock Neurotech, Precision Neuroscience, INBRAIN Neuroelectronics, Paradromics, Axoft, Motif Neurotech, and Science Corp—while mapping over 2,160 patent families across 664 entities to identify the companies, universities, and innovation clusters shaping the future of neurotechnology.

    Key Insights:

    • Strategic Leaders Are Emerging: While Neuralink commands visibility, Synchron is quietly establishing category leadership through a minimally invasive platform, global partnerships, and a highly targeted IP strategy spanning 10 jurisdictions. Other leaders—including INBRAIN, Blackrock, Precision Neuroscience, and Paradromics—are staking out defensible positions through differentiated technologies, clinical focus areas, and early IP consolidation.
    • Corporate IP Consolidation: More than 2,160 unique BCI patent families are now held by companies like NeuroPace, Neurolutions, Cognixion, Neurable, Snap (NextMind), Panasonic, Arctop, and CereGate—highlighting an accelerating arms race for control over system-level intellectual property.
    • Universities Still Control the Foundations: Academic institutions such as Tianjin University, Stanford, and the University of California continue to dominate early-stage innovation, holding foundational patents in neural signal processing, interface architecture, and adaptive systems—establishing the starting line for many of today's commercial efforts.

    "Neuralink may command the headlines, but it's companies like Synchron and INBRAIN that are quietly securing the innovation real estate that will shape the future of neurotechnology," said Will Rosellini, Chief IP Officer at PatentVest. "That's exactly why we built the PatentVest Pulse—to give boards and investors visibility into the IP dynamics that actually define market leadership, beyond the noise."

    Access the Full Report

    The PatentVest Pulse report is now available. Get the data, insights, and strategic intelligence behind the companies shaping the future of BCI: Access the full report here.

    For more information or inquiries, please contact [email protected].

    About PatentVest

    PatentVest, a division of MDB Capital Holdings (NASDAQ:MDBH), is the first integrated IP intelligence, strategy, and law firm to enable visionary companies to develop into technology leaders. By combining our proprietary database with a time proven IP diligence process and expert analysis, we deliver actionable insights on the IP landscape to help our clients make informed decisions and stay ahead of the curve. The trends and competitive insights in this report are powered by PatentVest's proprietary IP intelligence platform. Our reports keep a pulse on the key players, technologies, and opportunities shaping deep technology markets.



    Primary Logo

    Get the next $MDBH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MDBH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MDBH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-Founder Marlett Christopher A bought $442 worth of shares (100 units at $4.42) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      7/15/25 9:02:05 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • Co-Founder Marlett Christopher A bought $197 worth of shares (44 units at $4.48) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      6/26/25 5:00:51 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • Co-Founder Marlett Christopher A bought $6,457 worth of shares (1,565 units at $4.13) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      6/24/25 2:11:04 PM ET
      $MDBH
      Finance: Consumer Services
      Finance

    $MDBH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market

      DALLAS, TX , July 10, 2025 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP strategy and legal firm, today announced the release of The Next Era of Surgical Robotics, a new report that maps the most important shift in medtech since the rise of the da Vinci system. Built from analysis of more than 18,000 patent families, $4B in M&A activity, and deep dives into 28 robotic platforms, the report shows a sector no longer defined by a single system but by a race for platform defensibility. The findings challenge the assumption that surgical robotics is a saturated category. Despite more than 310 million surgeries performed globally each year, fewer than 6% involve robots. That num

      7/10/25 12:00:00 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • MDB Capital Holdings Announces Transitions In Its Board of Directors

      Addison, TX, June 02, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, today announced key leadership transitions within its Board of Directors. Matthew Hayden, a board director since July 2022, will step down effective June 30, 2025, to assume a newly created role as Entrepreneur in Residence. In this position, Mr. Hayden will continue to support MDB's mission by applying his three decades of experience as an operator, investor, and strategic advisor to help guide early-stage disruptive technology companies through launch and growth while significantly expanding the

      6/2/25 5:20:00 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • ClearSign Technologies Corporation Announces Changes to Board of Directors

      TULSA, Okla., May 27, 2025 /PRNewswire/ -- ClearSign Technologies Corporation (NASDAQ:CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion and sensing technologies that support decarbonization, improve operational and energy efficiency, enable the use of hydrogen as a fuel and enhance safety while dramatically reducing emissions, today announced that the Company's Board of Directors (the "Board") has voted to expand in size from five to seven directors and it appointed Anthony DiGiandomenico and Lou Basenese to fill such newly created vacancies and to serve as members of the Board, effective as of May 22, 2025. Further, on May 27, 2025, David M. Maley, a member o

      5/27/25 4:05:00 PM ET
      $CLIR
      $MDBH
      $PROP
      Industrial Machinery/Components
      Industrials
      Finance: Consumer Services
      Finance

    $MDBH
    Financials

    Live finance-specific insights

    See more
    • MDB Capital Holdings to Host First Quarter 2025 Results Conference Call on Wednesday May 21, 2025, at 4:30 p.m. Eastern Time

      Addison, Texas, May 14, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Wednesday May 21, 2025 at 4:30 p.m. Eastern Time to discuss its results for the first quarter 2025. A press release detailing these results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoom web

      5/14/25 8:55:00 AM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • MDB Capital Holdings to Host Fourth Quarter and Full Year 2024 Results Conference Call on Monday March 31, 2025, at 4:30 p.m. Eastern Time

      Addison, TX, March 24, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Monday March 31, 2025 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2024. A press release detailing these results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoo

      3/24/25 8:50:00 AM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time

      Addison, Texas, Nov. 15, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Thursday November 21, 2024 at 4:30 p.m. Eastern Time to discuss its results for the third quarter 2024. A press release detailing these results will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated milestones, as well as host a question-and-answer period. Investors can pre-register now for the Zoo

      11/15/24 9:05:00 AM ET
      $MDBH
      Finance: Consumer Services
      Finance

    $MDBH
    Leadership Updates

    Live Leadership Updates

    See more
    • MDB Capital Expands Board, Appoints Daniel Torpey as New Director

      Addison, Texas, June 20, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB Capital"), a public venture platform focused on launching category-leading deep technology companies, today announced the appointment of Daniel Torpey to its Board of Directors, effective June 17, 2024. With the addition of Torpey, the MDB Capital Board now comprises eight members. Torpey brings over 24 years of experience at Ernst & Young LLP (EY), where he currently serves as an Assurance Partner in the Forensic & Integrity Services practice. His expertise spans accounting, auditing, compliance, financial reporting, fraud detection, and corporate investigations. "Dan's breadth of kn

      6/20/24 9:15:00 AM ET
      $MDBH
      Finance: Consumer Services
      Finance

    $MDBH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-Founder Marlett Christopher A bought $442 worth of shares (100 units at $4.42) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      7/15/25 9:02:05 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • Co-Founder Marlett Christopher A bought $197 worth of shares (44 units at $4.48) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      6/26/25 5:00:51 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • Co-Founder Marlett Christopher A bought $6,457 worth of shares (1,565 units at $4.13) (SEC Form 4)

      4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

      6/24/25 2:11:04 PM ET
      $MDBH
      Finance: Consumer Services
      Finance

    $MDBH
    SEC Filings

    See more
    • MDB Capital Holdings LLC filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - MDB Capital Holdings, LLC (0001934642) (Filer)

      6/2/25 5:05:19 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • SEC Form 10-Q filed by MDB Capital Holdings LLC

      10-Q - MDB Capital Holdings, LLC (0001934642) (Filer)

      5/12/25 4:14:12 PM ET
      $MDBH
      Finance: Consumer Services
      Finance
    • MDB Capital Holdings LLC filed SEC Form 8-K: Other Events

      8-K - MDB Capital Holdings, LLC (0001934642) (Filer)

      4/10/25 8:03:37 PM ET
      $MDBH
      Finance: Consumer Services
      Finance